Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
6
7
9
10
11
12
13
14
18
19
20
21
23
27
28
30
12:00 AM - Hepatology 2021
31
1
2
3
4
Heart Care and Diseases 2021
2021-03-03    
All Day
Euro Heart Conference 2020 will join world-class professors, scientists, researchers, students, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, [...]
Gastroenterology and Digestive Disorders
2021-03-04 - 2021-03-05    
All Day
Gastroenterology Diseases is clearing a worldwide stage by drawing in 2500+ Gastroenterologists, Hepatologists, Surgeons going from Researchers, Academicians and Business experts, who are working in [...]
Environmental Toxicology and Ecological Risk Assessment
2021-03-04 - 2021-03-05    
All Day
Environmental Toxicology 2021 you can meet the world leading toxicologists, biochemists, pharmacologists, and also the industry giants who will provide you with the modern inventions [...]
Dermatology, Cosmetology and Plastic Surgery
2021-03-05 - 2021-03-06    
All Day
Market Analysis Speaking Opportunities Speaking Opportunities: We are constantly intrigued by hearing from professionals/practitioners who want to share their direct encounters and contextual investigations with [...]
World Dental Science and Oral Health Congress
2021-03-08 - 2021-03-09    
All Day
About The Webinar Conference Series LLC Ltd invites you to attend the 42nd World Dental Science and Oral Health Congress to be held in March 08-09, 2021 with the [...]
Euro Metabolomics & Systems Biology
2021-03-08 - 2021-03-09    
All Day
Euro Metabolomics 2021 will be a platform to investigate recent research and advancements that can be useful to the researchers. Metabolomics is a rapidly emerging [...]
International Summit on Industrial Engineering
2021-03-15 - 2021-03-16    
All Day
Industrial Engineering conference invites all the participants to attend International summit on Industrial Engineering during March15-16, 2021 Webinar. This has prompt keynotes, Oral talks, Poster [...]
Digital Health 2021
2021-03-15 - 2021-03-16    
All Day
The use of modern technologies and digital services is not only changing the way we communicate, they also offer us innovative ways for monitoring our [...]
Genetics and Molecular biology 2021
2021-03-15    
All Day
Human genetics is study of the inheritance of characteristics by children from parents. Inheritance in humans does not differ in any fundamental way from that [...]
Food Science and Food Safety
2021-03-16 - 2021-03-17    
All Day
Food Safety. It also provides the premier multidisciplinary forum for researchers, professors and educators to present and discuss the most recent innovations, trends, and concerns, [...]
Traditional and Alternative Medicine
2021-03-16 - 2021-03-17    
All Day
Traditional Medicine 2021 welcomes attendees, presenters, and exhibitors from all over the world. We are glad to invite you all to attend and register for [...]
Carbon and Advanced Energy Materials
2021-03-16 - 2021-03-17    
All Day
Materials Science 2021 was an enchanted achievement. We give incredible credits to the Organizing Committee and participants of Materials Science 2021 Conference. Numerous tributes from [...]
Advancements in Tuberculosis and Lung Diseases
2021-03-17 - 2021-03-18    
All Day
Tuberculosis is a communicable disease, caused by the infectious bacterium Mycobacterium tuberculosis. It affects the lungs and other parts of the body (brain, spine). People [...]
Herbal Medicine and Acupuncture 2021
2021-03-22 - 2021-03-23    
All Day
The event offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and [...]
Hospital Management and Health Care
2021-03-22 - 2021-03-23    
All Day
Healthcare system refers to the totality of resource that a society distributes with in organization and health facilities delivery for the aim of upholding or [...]
Hematology and Infectious Diseases
2021-03-22 - 2021-03-23    
All Day
Hematology is the discipline concerned with the production, functions, bone marrow, and diseases which are related to blood, blood proteins. The main aim of this [...]
Aquaculture & Marine Biology
2021-03-24 - 2021-03-25    
All Day
The 15th International Conference on Aquaculture & Marine Biology is delighted to welcome the participants from everywhere the planet to attend the distinguished conference scheduled [...]
Artificial Intelligence & Robotics 2021
2021-03-24 - 2021-03-25    
All Day
The Conference Series LLC Ltd organizes conferences around the world on all computer science subjects including Robotics and its related fields. Here we are happy [...]
Tissue Engineering & Regenerative Medicine
2021-03-24 - 2021-03-25    
All Day
Tissue Engineering & Regenerative Medicine mainly focuses on Stem Cell Research and Tissue Engineering. Stem cell Research includes stem cell treatment for various disease and [...]
Nursing Research and Evidence Based Practice
2021-03-25 - 2021-03-26    
12:00 am
Global Nursing Practice 2021 has been circumspectly organized with various multi and interdisciplinary tracks to accomplish the middle objective of the gathering that is to [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Earth & Environmental Science 2021
2021-03-26 - 2021-03-27    
All Day
Earth Science 2021 is the integration of new technologies in the field of environmental science to help Environmental Professionals harness the full potential of their [...]
Nanomaterials and Nanotechnology
2021-03-26 - 2021-03-27    
All Day
Nanomaterials are the elements which have at least one spatial measurement in the size range of 1 to 100 nanometre. Nanomaterials can be produced with [...]
Smart Materials and Nanotechnology
2021-03-29 - 2021-03-30    
All Day
Smart Material 2021 clears a stage to globalize the examination by introducing an exchange amongst ventures and scholarly associations and information exchange from research to [...]
World Nanotechnology Congress 2021
2021-03-29    
All Day
Nano Technology Congress 2021 provides you with a unique opportunity to meet up with peers from both academic circle and industries level belonging to Recent [...]
Nanomedicine and Nanomaterials 2021
2021-03-29    
All Day
NanoMed 2021 conference provides the best platform of networking and connectivity with scientist, YRF (Young Research Forum) & delegates who are active in the field [...]
Hepatology 2021
2021-03-30 - 2021-03-31    
All Day
Hepatology 2021 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas. The conference will cover a wide range [...]
Events on 2021-03-03
Events on 2021-03-05
Events on 2021-03-17
Events on 2021-03-25
Events on 2021-03-30
Hepatology 2021
30 Mar 21
Latest News

Fitch Rates Lexington Medical Center’s (SC) Series 2016 Bonds ‘A+’

Fitch Rates
Read More

Fitch Ratings has assigned an ‘A+’ rating to approximately $171 million in series 2016 bonds to be issued by the Lexington County Health Services District, Inc. (the District) on behalf of Lexington Medical Center (LMC).

In addition, Fitch has downgraded the rating to ‘A+’ from ‘AA-‘ on the following bonds issued by the District:

–$49.4 million fixed rate bonds series 2011;

–$172.8 million fixed rate bonds series 2007.

The Rating Outlook is Stable.

The series 2016 bonds are expected to be issued as fixed rate debt. The bonds will finance certain capital expansions at LMC, pay a portion of the interest accruing on the series 2016 bonds during the construction and provide for costs of issuance. The bonds are scheduled to sell via negotiated sale on the week of Aug. 8, 2016.

SECURITY

Debt payments are secured by a pledge of the gross receipts of the obligated group, which operates LMC and LexMed, a skilled nursing facility.

KEY RATING DRIVERS

INCREASED DEBT BURDEN: The downgrade to ‘A+’ reflects LMC’s elevated risk profile associated with a higher leverage position and a large pension liability. The increased balance sheet risk reduces financial flexibility for LMC in the medium term while operating in a competitive market. Pro forma cushion and cash to debt ratios decline to 21.1x and 139.6%, respectively, from 29.3x and 249.7%, making these metrics consistent with an ‘A’ category rating.

SIZABLE CAPITAL PLANS: LMC has begun construction on a $400 million project to expand its campus with the addition of a new patient tower and parking garage. The new tower will provide additional beds, neonatal ICU space and expanded operating room capacity, all of which are needed to accommodate capacity constraints due to high volume growth at LMC. Management may issue additional debt or use operating cash flow to fund the second half of its capital plans.

CONSISTENTLY STRONG OPERATING RESULTS: The District has a proven record of solid operating EBITDA margins (15.7% in fiscal 2015)) that has enabled it to build its unrestricted cash and investments in recent years. Days cash on hand (DCOH) was favorably robust at 276.8 days in fiscal 2015 (ended Sept. 30, 2015) and 258.1 days on March 31, 2016.

UTILIZATION GROWTH: Despite a highly competitive market, LMC continues to experience strong medical and surgical volume growth as a result of successful expansion strategies supported by a highly integrated physician platform and ambulatory network.

RATING SENSITIVITIES

STABILITY DURING CONSTRUCTION: The ‘A+’ rating incorporates the full impact of the $400 million capital expansion project planned through 2019. At the ‘A+’ rating, Lexington Medical Center is well positioned to absorb any inherent project risks. Over the longer term, moderation in leverage metrics while maintaining historical profitability could result in positive rating action.

CREDIT PROFILE

Located in West Columbia, South Carolina, the District includes Lexington Medical Center, which currently consists of a 428-operated bed acute care facility, six outpatient facilities providing urgent and primary care services, five medical office parks and a large employed physician network. The District also includes the Lexington Medical Center Extended Care (LexMed), a 388-bed skilled nursing facility. The District is a governmental entity but does not have any taxing authority nor does it receive any tax support. Fitch’s analysis is based on the District, which had operating revenues of $894.9 million in fiscal 2015.

STRATEGIC GROWTH

LMC operates in a relatively challenging market with significant competition, mostly from Palmetto Health (rated ‘BBB+’; Outlook Stable) but also from Providence Hospitals (acquired in 2016 by LifePoint Health). Due to Palmetto Health’s market presence in Richland County, LMC has historically focused its operations in its primary service area of Lexington County, where it holds the leading 56.6% market share. However, LMC has been capturing a modest increase in volume originating from its secondary service area of Richland County in recent years, where it holds an 11.5% market share.

Despite the competitive environment, LMC’s profitability has come from successfully integrating a large employed physician network that has generated increased referrals and revenues for the medical center. LMC has a long history of employing physicians and the losses per physician are low. The 301 employed physicians are mostly loyal to LMC’s culture and are a key driver of the strong utilization growth at the hospital.

LMC has also benefited from robust growth in cardiology and oncology (both programs are affiliated with Duke Health) and high surgical volume. Consequently, the Medicare case mix index (CMI) has continued to increase and was 1.87 through the first half of 2016.

LMC’s utilization growth has led to capacity constraints at the hospital and in its operating rooms. The volume demand can be taxing on the medical staff, which management is addressing by continuing its recruiting efforts in certain clinical lines. LMC’s track record of volume growth and consequent increases in revenue offsets the concern that this is a single-site medical center with limited geographic diversification.

CAPITAL EXPANSIONS

To address the capacity constraints and accommodate future growth, LMC has embarked on a large capital project of more than $400 million that includes the construction of a new 10-story patient tower and additional ancillary facilities (parking and medical office building). The plan is to add approximately 200 new beds (including critical care), observation beds, labor and recovery rooms, private neonatal ICU spaces, eight new operating rooms and two endoscopy suites.

The series 2016 bonds will provide approximately $190 million for the project fund. LMC may pursue an incremental financing in 2017 for the final half of the project, but it may decide to fund it with cash flow and investments instead. The decision will be made based on the District’s financial profile at the time. Whether financed with debt or funded with equity and cash flow, Fitch believes that the District has flexibility at the ‘A+’ rating to complete its capital plans without additional rating pressure.

Fitch expects minimal disruption from the construction as the project is contained on the north side of the existing tower. Therefore, Fitch believes that LMC will continue to generate strong EBITDA in 2016 and 2017, although most likely not at the higher fiscal 2015 level.

Operating Profile

The District generated strong profitability in 2015 through a combination of revenue growth, tight expense control, and a further decrease in self-pay volume. Self-pay decreased from 10.8% of gross revenues in 2013 to 7.2% in 2015, which management believes is related to a shift that occurred with the opening of Palmetto Parkridge but also overall economic improvement in the area. Operating EBITDA margin declined through the six-months of fiscal 2016 and was restated to 10.7% after a one-time adjustment for a $17 million revenue reduction combined with legal expenses related to a False Claims Act settlement that was paid to the Department of Justice in July. Prior to the adjustment, operating EBITDA margin was calculated at 14.4%, slightly lower than 18.6% in the same period of 2015, but still significantly above the median for the ‘AA’ rating category.

In addition to the campus expansion and the investments in its physician network, LMC is also planning to migrate its ambulatory sites to EPIC Ambulatory EHR and Practice Management Solutions. The revenue cycle component will go live in April 2017 and the full system is expected to be implemented by July 2017. The $45 million implementation is part of the 2017 capital budget. Although Fitch views the implementation favorably, the EPIC installation at the medical center in 2013 resulted in one-time costs that suppressed the operating margins in that fiscal year. Similarly, there may be additional one-time expenses in 2017 related to this implementation. Ultimately, however, the conversion will introduce a single integrated medical record and one patient portal for LMC, which is an important objective given LMC’s large ambulatory component.

Fitch expects the District’s liquidity position to remain a credit strength even if it decreases slightly with the upcoming elevated capital and strategic investments. Days cash on hand at March 31, 2016 measured 258.1 days from 268.8 days for the six-month period in 2015. Cash is expected to decrease by approximately 7.5 days with the $17 million settlement payment in July with the Department of Justice. LMC maintains no wrong-doing but has entered into a Corporate Integrity Agreement related to this matter.

DEBT PROFILE

The District has a conservative debt profile with all fixed rate debt and no swaps outstanding. Debt metrics remain strong even with the increase in pro forma maximum annual debt service (MADS) to $27.6 million. Pro forma MADS coverage of 5.3x and MADS as a percent of revenues of 3.2% are slightly weaker than the ‘AA-‘ median of 5.7x and 2.4%, respectively. Based on the 2016 interim statements shared with Fitch, we expect that EBITDA in 2016 will be moderately lower than in fiscal 2015. Consequently, coverage may decrease in 2016, but is still expected to compare favorably to the 4.2x median for the ‘A’ rating category.

Elevated leverage is also reflected in a very high pro forma debt-to-cap of 60.3%. The sharp increase for this metric is partly due to the incremental debt, but also due to a large pension liability that is the result of a new accounting guideline. The District participates in multi-employer defined benefit plans with the South Carolina State Retirement Plan and the South Carolina Police Officers Retirement System that are currently underfunded. Beginning with the fiscal 2015 audit, the District adopted GASB 68 that resulted in a large net pension liability based on the District’s proportionate contributions into the plans. The net pension liability totaled $569 million as of fiscal year end 2015, representing an increase from $503.2 million in 2014.

DISCLOSURE

The District covenants to provide annual and quarterly disclosure to bondholders through the Municipal Securities Rulemaking Board’s EMMA system with quarterly statements no later than 60 days after the end of each fiscal quarter and annual statements no later than 135 days after the end of the fiscal year. Disclosure has been timely and complete.

Additional information is available at ‘www.fitchratings.com‘.

Applicable Criteria

Revenue-Supported Rating Criteria (pub. 16 Jun 2014)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=750012

U.S. Nonprofit Hospitals and Health Systems Rating Criteria (pub. 09 Jun 2015)

https://www.fitchratings.com/creditdesk/reports/report_frame.cfm?rpt_id=866807

Additional Disclosures

Dodd-Frank Rating Information Disclosure Form

https://www.fitchratings.com/creditdesk/press_releases/content/ridf_frame.cfm?pr_id=1009659

Solicitation Status

https://www.fitchratings.com/gws/en/disclosure/solicitation?pr_id=1009659

Endorsement Policy

https://www.fitchratings.com/jsp/creditdesk/PolicyRegulation.faces?context=2&detail=31

ALL FITCH CREDIT RATINGS ARE SUBJECT TO CERTAIN LIMITATIONS AND DISCLAIMERS. PLEASE READ THESE LIMITATIONS AND DISCLAIMERS BY FOLLOWING THIS LINK: HTTP://FITCHRATINGS.COM/UNDERSTANDINGCREDITRATINGS. IN ADDITION, RATING DEFINITIONS AND THE TERMS OF USE OF SUCH RATINGS ARE AVAILABLE ON THE AGENCY’S PUBLIC WEBSITE ‘WWW.FITCHRATINGS.COM‘. PUBLISHED RATINGS, CRITERIA AND METHODOLOGIES ARE AVAILABLE FROM THIS SITE AT ALL TIMES. FITCH’S CODE OF CONDUCT, CONFIDENTIALITY, CONFLICTS OF INTEREST, AFFILIATE FIREWALL, COMPLIANCE AND OTHER RELEVANT POLICIES AND PROCEDURES ARE ALSO AVAILABLE FROM THE ‘CODE OF CONDUCT’ SECTION OF THIS SITE. FITCH MAY HAVE PROVIDED ANOTHER PERMISSIBLE SERVICE TO THE RATED ENTITY OR ITS RELATED THIRD PARTIES. DETAILS OF THIS SERVICE FOR RATINGS FOR WHICH THE LEAD ANALYST IS BASED IN AN EU-REGISTERED ENTITY CAN BE FOUND ON THE ENTITY SUMMARY PAGE FOR THIS ISSUER ON THE FITCH WEBSITE.

Contacts

Fitch Ratings
Primary Analyst
Olga Beck
Director
+1-212-908-0772
Fitch Ratings, Inc.
33 Whitehall Street
New York, NY 10004
or
Secondary Analyst
Ryan Pami
Associate Director
+1-212-908-0803
or
Committee Chairperson
Jim LeBuhn
Senior Director
+1-312-368-2059
or
Media Relations
Elizabeth Fogerty
+1-212-908-0526
New York
elizabeth.fogerty@fitchratings.com

Source